OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
20 hedge funds and large institutions have $2.26M invested in OncoSec Medical Incorporated in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
5% less funds holding
Funds holding: 21 → 20 (-1)
6% less capital invested
Capital invested by funds: $2.41M → $2.26M (-$148K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$245K |
| 2 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$39.7K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$24.8K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$12.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$123K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$85K |
| 3 |
BlackRock
New York
|
-$43.9K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$17.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$13K |
ONCS Hedge Fund Activity: Q2 2017 in Review
20 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2017, worth a combined $2.26M — down 6.2% from $2.41M a quarter earlier.
Fund positioning in ONCS was balanced in Q2 2017: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, adding an estimated $245K. The largest seller was Vanguard Group, cutting an estimated $123K.
- 20 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2017, down from 21 in Q1 2017.
- Funds reported $2.26M of OncoSec Medical Incorporated stock for Q2 2017, down 6.2% quarter-over-quarter.
- 3 funds opened new OncoSec Medical Incorporated positions in Q2 2017 and 3 closed out, a net change of 0 holders.
- The largest OncoSec Medical Incorporated buyer in Q2 2017 was Millennium Management, an estimated $245K added.
- The largest OncoSec Medical Incorporated seller in Q2 2017 was Vanguard Group, an estimated $123K sold.
Based on aggregated 13F filings for Q2 2017.